Clinical Trial Update: A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

View source ↗

Summary

Hoffmann-La Roche reports a real-world, observational study to gain clinical insights into Roche ophthalmology products across several retinal diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion
• Central Retinal Vein Occlusion
• Diabetic Macular Edema
• Hemiretinal Vein Occlusion
• Neovascular Age-related Macular Degeneration
• Retinal Vein Occlusion

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Neovascular Age-related Macular Degeneration, Diabetic Macular Edema | Status: ACTIVE_NOT_RECRUITING